documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

15 rows where docket_id = "FDA-2012-D-0307" and posted_year = 2017 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 3

posted_year 1

  • 2017 · 15 ✖

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2012-D-0307-0023 FDA None FDA-2012-D-0307 Reference 37-Regulation (EC) No 999_2001 of EU Parliament re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2020-02-25T15:38:29Z   0 0 0900006482d5883c
FDA-2012-D-0307-0013 FDA None FDA-2012-D-0307 Reference 01 - Revised Preventive Measures to Reduce the Possible Risk of Transmission of CJD and vCJD by blood and blood products re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2017-12-22T16:24:28Z   0 0 0900006482d5882c
FDA-2012-D-0307-0010 FDA None FDA-2012-D-0307 Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Notice Notice of Availability 2017-12-22T05:00:00Z 2017 12 2017-12-22T05:00:00Z 2018-03-23T03:59:59Z 2018-01-06T02:01:16Z 2017-27569 0 0 0900006482d56ac6
FDA-2012-D-0307-0016 FDA None FDA-2012-D-0307 Referecne 28-Gregori_et_al-2011-Transfusion re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2020-02-25T15:36:55Z   0 0 0900006482d58830
FDA-2012-D-0307-0021 FDA None FDA-2012-D-0307 Reference 35-Schlicter S.J. (1997)TRAP Study re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2020-02-25T15:37:58Z   0 0 0900006482d58838
FDA-2012-D-0307-0015 FDA None FDA-2012-D-0307 Reference 25-Yang_et_al-2017-Transfusion re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2020-02-25T15:36:39Z   0 0 0900006482d5882e
FDA-2012-D-0307-0020 FDA None FDA-2012-D-0307 Reference 34-King_LR reduced RBC rxn_Tx_'04 re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2020-02-25T15:37:48Z   0 0 0900006482d58835
FDA-2012-D-0307-0011 FDA None FDA-2012-D-0307 Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Other Guidance 2017-12-22T05:00:00Z 2017 12 2017-12-22T05:00:00Z 2018-03-23T03:59:59Z 2024-11-07T01:15:24Z   1 0 0900006482d58385
FDA-2012-D-0307-0019 FDA None FDA-2012-D-0307 Reference 32-Transfusion-medicine-epidemiology-review-tmer re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2020-02-25T15:37:39Z   0 0 0900006482d58833
FDA-2012-D-0307-0018 FDA None FDA-2012-D-0307 Reference 31-McCutcheon_et_al-2011-PloSOne re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2020-02-25T15:37:23Z   0 0 0900006482d58832
FDA-2012-D-0307-0022 FDA None FDA-2012-D-0307 Referenec 36-Bowden_LR v seroneg_Blood '95 re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2020-02-25T15:38:22Z   0 0 0900006482d5883b
FDA-2012-D-0307-0024 FDA None FDA-2012-D-0307 Reference 38-FDA Transmissible Spongiform Encephalopathies Advisory Committee re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2020-02-25T15:38:38Z   0 0 0900006482d5883d
FDA-2012-D-0307-0014 FDA None FDA-2012-D-0307 Reference 19-Swiss Med Wkly re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2017-12-22T16:24:59Z   0 0 0900006482d5882d
FDA-2012-D-0307-0017 FDA None FDA-2012-D-0307 Reference 29-Harvey_et_al-2015-Transfusion re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2020-02-25T15:37:08Z   0 0 0900006482d58831
FDA-2012-D-0307-0012 FDA None FDA-2012-D-0307 Reference List re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2017-12-22T16:24:07Z   0 0 0900006482d587fd

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;